NAME | DATE | TM | OPP | DK | FD | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | L. Markkanen | 11/3/2017 | CHI | @ | ORL | 29.3 | 26.3 | 29 | 13 | 9 | 3 | 0 | 0 | 5 | 10 | 50.0 | 3 | 4 | 75.0 | 0 | 0 | 65.0 | 2 | 7 | 2 | 1 | +12 | ||
2 | L. Markkanen | 12/20/2017 | CHI | vs | ORL | 17.3 | 18 | 20 | 9 | 5 | 0 | 0 | 1 | 3 | 10 | 30.0 | 0 | 4 | 0.0 | 3 | 3 | 100.0 | 39.8 | 1 | 4 | 0 | 2 | +17 | |
3 | L. Markkanen | 2/12/2018 | CHI | vs | ORL | 32 | 31.6 | 31 | 21 | 8 | 0 | 0 | 1 | 9 | 19 | 47.4 | 0 | 6 | 0.0 | 3 | 3 | 100.0 | 51.7 | 3 | 5 | 2 | 1 | -1 | |
4 | L. Markkanen | 3/30/2018 | CHI | @ | ORL | 30 | 31.1 | 24 | 13 | 8 | 1 | 2 | 1 | 4 | 10 | 40.0 | 1 | 5 | 20.0 | 4 | 5 | 80.0 | 53.3 | 0 | 8 | 2 | 1 | +6 | |
5 | L. Markkanen | 12/13/2018 | CHI | @ | ORL | 17.8 | 18 | 28 | 7 | 5 | 0 | 1 | 1 | 2 | 10 | 20.0 | 2 | 6 | 33.3 | 1 | 2 | 50.0 | 32.2 | 0 | 5 | 1 | 1 | -9 | |
6 | L. Markkanen | 12/21/2018 | CHI | vs | ORL | 47 | 44.7 | 37 | 32 | 6 | 3 | 0 | 1 | 12 | 20 | 60.0 | 4 | 6 | 66.7 | 4 | 4 | 100.0 | 73.5 | 0 | 6 | 2 | 5 | +2 | |
7 | L. Markkanen | 1/2/2019 | CHI | vs | ORL | 27.5 | 27.7 | 28 | 14 | 6 | 1 | 2 | 0 | 6 | 12 | 50.0 | 2 | 3 | 66.7 | 0 | 0 | 58.3 | 2 | 4 | 1 | 1 | -15 | ||
8 | L. Markkanen | 2/22/2019 | CHI | @ | ORL | 46.8 | 43.2 | 38 | 25 | 11 | 2 | 1 | 0 | 8 | 21 | 38.1 | 4 | 10 | 40.0 | 5 | 6 | 83.3 | 52.9 | 0 | 11 | 1 | 4 | +2 | |
9 | L. Markkanen | 12/23/2019 | CHI | @ | ORL | 19.8 | 19.6 | 30 | 10 | 3 | 2 | 0 | 1 | 4 | 11 | 36.4 | 2 | 7 | 28.6 | 0 | 0 | 45.5 | 0 | 3 | 0 | 0 | +1 | ||
10 | L. Markkanen | 2/5/2021 | CHI | @ | ORL | 19.8 | 18 | 17 | 13 | 5 | 0 | 0 | 0 | 5 | 9 | 55.6 | 2 | 5 | 40.0 | 1 | 1 | 100.0 | 68.9 | 0 | 5 | 1 | 2 | -16 | |
11 | L. Markkanen | 4/14/2021 | CHI | vs | ORL | 10.3 | 10.2 | 17 | 6 | 1 | 0 | 1 | 0 | 2 | 6 | 33.3 | 2 | 5 | 40.0 | 0 | 0 | 50.0 | 0 | 1 | 0 | 0 | +2 | ||
12 | L. Markkanen | 11/27/2021 | CLE | vs | ORL | 27.8 | 25 | 32 | 20 | 5 | 0 | 0 | 0 | 8 | 13 | 61.5 | 4 | 8 | 50.0 | 0 | 0 | 76.9 | 2 | 3 | 1 | 0 | +11 | ||
13 | L. Markkanen | 3/28/2022 | CLE | vs | ORL | 24.3 | 21.6 | 29 | 20 | 3 | 0 | 0 | 0 | 6 | 15 | 40.0 | 3 | 9 | 33.3 | 5 | 5 | 100.0 | 58.1 | 0 | 3 | 2 | 3 | +11 | |
14 | L. Markkanen | 4/5/2022 | CLE | @ | ORL | 38.5 | 37.3 | 35 | 25 | 4 | 1 | 0 | 2 | 7 | 16 | 43.8 | 6 | 12 | 50.0 | 5 | 5 | 100.0 | 68.7 | 0 | 4 | 0 | 3 | +2 | |
15 | L. Markkanen | 1/13/2023 | UTA | vs | ORL | 50.5 | 46.4 | 36 | 28 | 12 | 2 | 1 | 1 | 4 | 13 | 30.8 | 3 | 6 | 50.0 | 17 | 21 | 81.0 | 62.9 | 1 | 11 | 5 | 2 | +8 | |
16 | L. Markkanen | 3/9/2023 | UTA | @ | ORL | 42.8 | 41 | 34 | 31 | 5 | 2 | 0 | 1 | 11 | 22 | 50.0 | 3 | 9 | 33.3 | 6 | 6 | 100.0 | 62.9 | 1 | 4 | 2 | 2 | +13 | |
17 | L. Markkanen | 11/2/2023 | UTA | vs | ORL | 36.8 | 34.9 | 33 | 22 | 7 | 1 | 2 | 0 | 9 | 17 | 52.9 | 4 | 10 | 40.0 | 0 | 2 | 0.0 | 61.5 | 1 | 6 | 3 | 4 | +2 | |
18 | L. Markkanen | 2/29/2024 | UTA | @ | ORL | 25.3 | 23.6 | 34 | 18 | 3 | 0 | 1 | 0 | 6 | 15 | 40.0 | 4 | 7 | 57.1 | 2 | 2 | 100.0 | 56.7 | 2 | 1 | 1 | 2 | 0 | |
Average | 30.2 | 28.8 | 29.5 | 18.2 | 5.9 | 1.0 | 0.6 | 0.6 | 6.2 | 13.8 | 44.6 | 2.7 | 6.8 | 40.2 | 3.1 | 3.6 | 86.2 | 58.9 | 0.8 | 5.1 | 1.4 | 1.9 | 2.7 | ||||||
Total | 543 | 518.2 | 531 | 327 | 106 | 18 | 11 | 10 | 111 | 249 | 44.6 | 49 | 122 | 40.2 | 56 | 65 | 86.2 | 58.9 | 15 | 91 | 26 | 34 | +48 |